Discover 1,665 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,665
Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain
for
Osteoarthritis Knee Pain
Location: Washington D.C. DC, Richmond VA, Altoona PA,
Sponsor: Saol Therapeutics Inc
Sex: All
Age: 40+
Code: NCT07226258
Phase3, Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
for
Pulmonary Arterial Hypertension (PAH),
Location: Philadelphia PA, Washington D.C. DC, Jacksonville FL,
Sponsor: AllRock Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07175038
Phase2, Recruiting
Propranolol for Misophonia
for
Misophonia, Propanolol, Misophonia Treatment
Location: Littleton CO
Sponsor: Bloom Mental Health, LLC
Sex: All
Age: 18 - 65
Code: NCT07271485
Early_phase1, Recruiting
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
for
CADASIL
Location: Providence RI, New York NY, Atlanta GA, Chicago IL,
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT05677880
Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for
Multiple Sclerosis
Location: Teaneck NJ, Raleigh NC, West Palm Beach FL,
Sponsor: Sanofi
Sex: All
Age: 18 - 60
Code: NCT07325292
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)